STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLANDER'S BACILLUS : I. THE PATHOGENESIS OF EXPERIMENTAL

L Sale1, W B Wood

  • 1Department of Medicine and the Oscar Johnson Institute for Medical Research, Washington University School of Medicine, St. Louis.

Insights

Friedländer

Area of Science:

  • Microbiology
  • Pathology
  • Infectious Diseases

Background:

  • Friedländer's bacillus can cause severe pneumonia.
  • Understanding its pathogenesis is crucial for treatment.

Purpose of the Study:

  • To investigate the pathogenesis of Friedländer's bacillus pneumonia in rats.
  • To compare it with pneumococcal pneumonia.

Main Methods:

  • Intrabronchial inoculation of rats with Friedländer's bacillus in mucin.
  • Microscopic examination of lung tissues at intervals.

Main Results:

  • Friedländer's pneumonia in rats is lobar, fatal, and mimics human disease.
  • Histology shows more bacteria, frequent abscesses, and organized exudate compared to pneumococcal pneumonia.
  • Lesion spread and phagocytosis mechanisms are similar to pneumococcal pneumonia.

Conclusions:

  • Friedländer's bacillus causes a distinct form of pneumonia with unique pathological features.
  • The study provides insights into bacterial pneumonia pathogenesis.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: